KI-7（Cat No.:I014777）is a small-molecule inhibitor developed as a research tool to target protein kinases involved in cellular signaling and disease progression. By modulating kinase activity, KI-7 helps researchers dissect mechanisms of cell proliferation, apoptosis, and differentiation. It is particularly useful in cancer biology and immunology, where dysregulated kinase pathways drive tumor growth and immune responses. KI-7 supports studies on structure–activity relationships, drug resistance, and pathway selectivity. Its defined activity profile makes it a versatile compound for advancing kinase-focused therapeutic strategies and preclinical drug discovery research.